From the Cardiology Division, Department of Medicine, University of California San Diego, La Jolla, California.
Department of Cardiothoracic Surgery, University of California San Diego, La Jolla, California.
ASAIO J. 2019 May/Jun;65(4):e36-e41. doi: 10.1097/MAT.0000000000000890.
Patients with biventricular assist devices (BIVAD) are severely critically ill compared with patients who receive left ventricular assist device (LVAD) support alone and portend a significant risk for greater adverse events including pump thrombosis (PT). Current approaches to treat PT are limited to LVAD with variable outcomes depending on the management strategy implemented. Moreover the management of PT in patients with BIVAD support, specifically to the right ventricular assist device (RVAD), is unknown. We describe the first care series to date on the management of PT in patients with durable right ventricular assist device and their outcomes.
与仅接受左心室辅助装置 (LVAD) 支持的患者相比，双心室辅助装置 (BIVAD) 的患者病情严重危急，预示着发生更大不良事件（包括泵血栓形成 (PT)）的风险显著增加。目前治疗 PT 的方法仅限于 LVAD，但根据实施的管理策略，其结果存在差异。此外，对于接受 BIVAD 支持的患者（特别是右心室辅助装置 (RVAD)），PT 的管理尚不清楚。我们描述了迄今为止首例关于耐用性 RVAD 患者 PT 管理及其结果的护理系列。
